Skip to main content
. 2022 Oct 12;127(10):1827–1836. doi: 10.1038/s41416-022-01951-y

Fig. 4. Star plot illustrating the distribution of treatment regimens across the included studies.

Fig. 4

BTKi Bruton Tyrosine Kinase Inhibitor, Anti-CD20 CD20 targetted therapy.